A statistical information site that deepens
the understanding of AMR (drug resistance) and one health

MENU
Abbreviations Types and Abbreviations of Antimicrobials References
Japanese English
Trends in the proportion (%) of antimicrobial-resistant bacteria and infectious disease Trends in antimicrobial consumption Public Awareness

A statistical information site that deepens the understanding of AMR (drug resistance) and one health

JP EN
Abbreviations Types and Abbreviations of Antimicrobials References
btn

Trends in the proportion (%) of IPM and MEPM-resistant Escherichia coli and parenteral Carbapenems consumption calculated from the sales[the proportion of antimicrobial resistance and antimicrobial consumption in humans]

Trends in the proportion (%) of antimicrobial-resistant bacteria and infectious disease
Trends in antimicrobial consumption
Public Awareness
Search

Source

Japan Nosocomial Infections Surveillance (JANIS)

https://janis.mhlw.go.jp/english/index.asp

IQVIA Solutions Japan K.K.

https://www.iqvia.com/ja-jp/locations/japan/about-iqvia-japan

The data were obtained from two different sources: Japan Nosocomial Infections Surveillance (JANIS) and IMS Japan Pharmaceutical Market database. Please note that targets of the surveys are different.

Graph
Table
Download
Trends in the proportion (%) of IPM and MEPM-resistant Escherichia coli and parenteral Carbapenems consumption calculated from the sales[the proportion of antimicrobial resistance and antimicrobial consumption in humans]
Trends in the proportion (%) of IPM and MEPM-resistant Escherichia coli and parenteral Carbapenems consumption calculated from the sales[the proportion of antimicrobial resistance and antimicrobial consumption in humans]

Trends in the proportion (%) of IPM and MEPM-resistant Escherichia coli and parenteral Carbapenems consumption calculated from the sales[the proportion of antimicrobial resistance and antimicrobial consumption in humans](0151.xlsx)

The unit of BP is μg/mL.
-: Not under surveillance.
CLSI (2007) (M100-S17) Criteria was applied to determine the BP up to 2013. CLSI (2012)(M100-S22) Criteria was applied to determine BP after 2014.
As a unit of consumption, defined daily doses (DDDs) per 1,000 inhabitants per day (DID) is used.
Figures shown here for antimicrobial use in 2013 differ from those shown in last year’s report, because of differences in the DDD values defined by the World Health Organization at the time of calculation. Figures do not include antifungal agents.
＊ The user must cite the source when using the Information on this page.Nippon AMR One Health Report (NAOR) 2018(Examples of source citation)
"Source: Nippon AMR One Health Report (NAOR) 2018"